Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Art Krieg, Brian Gallager, Stephen Padgette

Premium

Startup Rana Therapeutics has named Art Krieg as its president and CEO.

Krieg was most recently an entrepreneur in residence at venture capital firm and Rana investor Atlas Venture. Before that, he served as head of Pfizer's oligonucleotide therapeutics unit.

In conjunction with the close of a Series A round of financing, Rana has also appointed two new board members: Brian Gallagher, a partner at Rana investor SR One, and Stephen Padgette, a vice president at Rana investor and ag-bio firm Monsanto.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.